
GC10627
Erlotinib
Also known as N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
Erlotinib is a potent and orally bioavailable epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with an IC50 value of 2 nM
ChemicalCAS183321-74-6MW393.44FormulaC22H23N3O4
- CAS number
- 183321-74-6
- Molecular weight
- 393.44
- Formula
- C22H23N3O4
- Solubility
- ≥ 19·65 mg/mL in DMSO, ≥ 30·27 mg/mL in EtOH with gentle warming
- InChIKey
- AAKJLRGGTJKAMG-UHFFFAOYSA-N
- Catalogue number
- GC10627
- Brand
- GLPBIO
Computed properties PubChem CID 176870 · XLogP 3.3 · TPSA 74.7 Ų · H-bond donors 1
- XLogP
- 3.3
- TPSA
- 74.7 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Rotatable bonds
- 11
- Heavy atoms
- 29
SMILES COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
Computed descriptors from PubChem (CID 176870), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il